Items where authors include "Distler, O."

Article

Kistler-Fischbacher, M., Armbrecht, G., Da Silva, J.A.P. et al. (75 more authors) (2025) Effects of vitamin D3, omega-3s, and a simple home exercise program on incident vertebral fractures: the DO-HEALTH randomized controlled trial. Journal of Bone and Mineral Research, 40 (9). pp. 1035-1044. ISSN 0884-0431

Sabanovic, H. orcid.org/0000-0002-2759-8781, Pauling, J.D., Baron, M. et al. (17 more authors) (2025) ‘Am I doing this right?’ Physician perceptions of the global assessment in clinical trials of systemic sclerosis. Rheumatology. keaf377. ISSN 1462-0324 (In Press)

Sobanski, V., de Vries-Bouwstra, J., Hoffmann-Vold, A.-M. et al. (102 more authors) (2025) Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study. Rheumatology. keaf264. ISSN 1462-0324

Di Donato, S. orcid.org/0000-0003-1256-0761, Pauling, J.D., Ramjug, S. et al. (149 more authors) (2025) Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort. Rheumatology. keaf290. ISSN 1462-0324

Campochiaro, C., Suliman, Y.A., Giuggioli, D. et al. (21 more authors) (2025) Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'. Journal of Scleroderma and Related Disorders. ISSN 2397-1983

Yan, Q., Bruni, C., Garaiman, A. et al. (25 more authors) (2025) Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database. Annals of the Rheumatic Diseases, 84 (4). pp. 620-631. ISSN 0003-4967

Bellando-Randone, S., Wilhalme, H., Bruni, C. et al. (15 more authors) (2025) The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort. Arthritis Research & Therapy, 27. 66. ISSN 1478-6354

Bjørkekjær, H.J., Bruni, C., Broch, K. et al. (60 more authors) (2025) A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. Rheumatology. keaf053. ISSN 1462-0324

Roth, E., Bruni, C., Petelytska, L. et al. (244 more authors) (2025) Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology. keaf016. ISSN 1462-0324

Del Galdo, F. orcid.org/0000-0002-8528-2283, Lescoat, A., Conaghan, P.G. orcid.org/0000-0002-3478-5665 et al. (23 more authors) (2025) EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Annals of the Rheumatic Diseases, 84 (1). pp. 29-40. ISSN 0003-4967

Del Galdo, F. orcid.org/0000-0002-8528-2283, Lescoat, A., Conaghan, P.G. orcid.org/0000-0002-3478-5665 et al. (23 more authors) (2025) EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Annals of the Rheumatic Diseases, 84 (1). pp. 29-40. ISSN 0003-4967

Mongin, D., Matucci‐Cerinic, M., Walker, U.A. et al. (16 more authors) (2024) Oral glucocorticoids for skin fibrosis in early diffuse systemic sclerosis: a target trial emulation study from the European Scleroderma Trials and Research group database. Arthritis Care & Research. ISSN 2151-464X

Wyss, A., Jordan, S., Graf, N. et al. (18 more authors) (2024) Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis. Arthritis Research & Therapy, 26. 187. ISSN 1478-6354

Colalillo, A., Hachulla, E., Pellicano, C. et al. (35 more authors) (2024) Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis. Chest Journal, 166 (4). pp. 837-844. ISSN 0012-3692

Mengis, T. orcid.org/0009-0000-5595-5224, Bernhard, L., Nüesch, A. orcid.org/0000-0002-0962-8705 et al. (10 more authors) (2024) The expression of toll-like receptors in cartilage endplate cells: a role of toll-like receptor 2 in pro-inflammatory and pro-catabolic gene expression. Cells, 13 (17). 1402. ISSN 2073-4409

Alunno, A., Carubbi, F., Tan, A.L. orcid.org/0000-0002-9158-7243 et al. (13 more authors) (2024) COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study. Rheumatology International, 44 (9). pp. 1725-1731. ISSN 0172-8172

Ruscitti, P., Allanore, Y., Baldini, C. et al. (70 more authors) (2024) Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus. Autoimmunity Reviews, 23 (7-8). 103581. ISSN 1568-9972

Velauthapillai, A., Bootsma, M.F.R., Bruni, C. et al. (118 more authors) (2024) Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. Rheumatology. keae375. ISSN 1462-0324

Kistler-Fischbacher, M., Armbrecht, G., Gängler, S. et al. (76 more authors) (2024) Effects of vitamin D3, omega-3s, and a simple strength training exercise program on bone health: the DO-HEALTH randomized controlled trial. Journal of Bone and Mineral Research, 39 (6). pp. 661-671. ISSN 0884-0431

Andreoli, L., Lini, D., Schreiber, K. et al. (184 more authors) (2024) COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study. Rheumatology, 63 (5). pp. 1341-1351. ISSN 1462-0324

Yoshida, A., Li, Y., Maroufy, V. et al. (184 more authors) (2024) Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey. Rheumatology Advances in Practice, 8 (2). rkae028. ISSN 2514-1775

Deibel, E. orcid.org/0000-0003-4652-9826, Carreira, P.E., Vonk, M. orcid.org/0000-0002-2266-9907 et al. (61 more authors) (2024) Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time? Arthritis Care & Research, 76 (1). pp. 88-97. ISSN 2151-464X

Lepri, G., Bruni, C. orcid.org/0000-0003-2813-2083, Tofani, L. orcid.org/0000-0001-9965-7667 et al. (23 more authors) (2024) The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database. Diagnostics, 14 (3). ARTN 295. ISSN 2075-4418

Spiera, R. orcid.org/0000-0003-2911-6800, Kuwana, M. orcid.org/0000-0001-8352-6136, Khanna, D. orcid.org/0000-0003-1412-4453 et al. (28 more authors) (2023) Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology, 75 (9). pp. 1608-1618. ISSN 2326-5191

Lescoat, A., Huang, S., Carreira, P.E. et al. (219 more authors) (2023) Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatology, 159 (8). pp. 837-847. ISSN 2168-6068

Lescoat, A., Huscher, D., Schoof, N. et al. (204 more authors) (2023) Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region. Rheumatology, 62 (6). pp. 2178-2188. ISSN 1462-0324

Hughes, M., Huang, S., Alegre-Sancho, J.J. et al. (98 more authors) (2023) Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology, 62 (SI). SI54-SI63. ISSN 1462-0324

Garaiman, A., Steigmiller, K., Gebhard, C. et al. (171 more authors) (2023) Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. Rheumatology, 62 (SI). SI91-SI100. ISSN 1462-0324

Kuster, S., Jordan, S., Elhai, M. et al. (104 more authors) (2022) Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open, 8 (2). e002477. ISSN 2056-5933

Campochiaro, C. orcid.org/0000-0001-6806-3794, Hoffmann-Vold, A.-M. orcid.org/0000-0001-6467-7422, Avouac, J. et al. (90 more authors) (2022) Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis. Rheumatology, 62 (7). pp. 2483-2491. ISSN 1462-0324

Elhai, M., Sritharan, N., Boubaya, M. et al. (167 more authors) (2022) Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. The Lancet Rheumatology, 4 (11). e785-e794. ISSN 2665-9913

Hoeper, M.M., Dwivedi, K., Pausch, C. et al. (39 more authors) (2022) Phenotyping of idiopathic pulmonary arterial hypertension : a registry analysis. The Lancet Respiratory Medicine, 10 (10). pp. 937-948. ISSN 2213-2600

Stahl-Gugger, A., de Godoi Rezende Costa Molino, C., Wieczorek, M. et al. (66 more authors) (2022) Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial. Aging Clinical and Experimental Research, 34 (9). pp. 2205-2215. ISSN 1594-0667

Lazzaroni, M-G., Marasco, E., Campochiaro, C. et al. (30 more authors) (2021) The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort. Rheumatology, 60 (11). pp. 5028-5041. ISSN 1462-0324

Hoffmann-Vold, A.-M., Allanore, Y., Alves, M. et al. (87 more authors) (2021) Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Annals of the Rheumatic Diseases, 80 (2). pp. 219-227. ISSN 0003-4967

Peytrignet, S., Denton, C.P., Lunt, M. et al. (60 more authors) (2018) Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology, 57 (2). pp. 370-381. ISSN 1462-0324

Herrick, A.L., Pan, X., Peytrignet, S. et al. (61 more authors) (2017) Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases. ISSN 0003-4967

Conference or Workshop Item

Campochiaro, C., Mongin, D., Courvoisier, D.S. et al. (16 more authors) (2025) OP0082 Evidence-based detection of progression of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPF study (CP number 148). In: EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain.

Roth, E., Bruni, C., Petelytska, L. et al. (18 more authors) (2024) POS0230 Characteristics and disease course of SSc-ILD patients with gastroesophageal reflux – an analysis of the EUSTAR cohort. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

Proceedings Paper

Burja, B., Boubaya, M., Bruni, C. et al. (21 more authors) (2025) OP0081 Anti-Ro/SSA+/RF+ double seropositivity in systemic sclerosis is associated with more severe interstitial lung disease: A study from the EUSTAR database. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , pp. 71-72.

Burja, B., Boubaya, M., Bruni, C. et al. (21 more authors) (2025) OP0081 Anti-Ro/SSA+/RF+ double seropositivity in systemic sclerosis is associated with more severe interstitial lung disease: A study from the EUSTAR database. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. , pp. 71-72.

Campochiaro, C., Mongin, D., Courvoisier, D.S. et al. (16 more authors) (2025) OP0082 Evidence-based detection of progression of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPF study (CP number 148). In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , pp. 72-73.

Colic, J., Campochiaro, C., Del Papa, N. et al. (17 more authors) (2025) OP0216 DISEASE CHARACTERISTICS OF ANTI-CENTROMERE POSITIVE SYSTEMIC SCLEROSIS PATIENTS AND RISK FACTORS FOR ORGAN INVOLVEMENT: DATA FROM THE EUSTAR COHORT. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , pp. 179-180.

Guler, A.A., Hughes, M., De Luca, G. et al. (17 more authors) (2025) OP0219 CLINICAL CHARACTERISTICS AND RISK FACTORS FOR CALCINOSIS CUTIS IN SYSTEMIC SCLEROSIS: INSIGHTS FROM THE EUROPEAN SCLERODERMA TRIAL AND RESEARCH GROUP (EUSTAR) DATABASE. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , pp. 183-184.

Bjørkekjær, H.J., Bruni, C., Broch, K. et al. (27 more authors) (2025) OP0333 INITIAL THERAPY IN SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION IMPROVES OUTCOMES ACROSS HAEMODYNAMIC THRESHOLDS AND RISK STRATIFICATION: INSIGHTS FROM THE EUSTAR DATABASE. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , pp. 269-271.

Burja, B., Welsing, P.M.J., Lescoat, A. et al. (16 more authors) (2025) POS0266 DEVELOPMENT OF AN ARTICULAR SCORE IN SYSTEMIC SCLEROSIS (ASSESS): IDENTIFICATION OF CORE INSTRUMENTS TO ASSESS DISEASE ACTIVITY. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , pp. 532-533.

Burja, B., Boubaya, M., Bruni, C. et al. (16 more authors) (2024) OP0013 ANTI-Ro/SSA ANTIBODIES ARE PREDICTIVE OF A MORE SEVERE LUNG INVOLVEMENT IN PATIENTS WITH SYSTEMIC SCLEROSIS: A STUDY FROM THE EUSTAR HDATABASE. In: Annals of the Rheumatic Diseases. EULAR 2024 Congress, 12-15 Jun 2025, Vienna, Austria. Elsevier , pp. 1-2.

Mongin, D., Matucci-Cerinic, M., Walker, U. et al. (15 more authors) (2024) POS0832 Immunosuppression Versus Combination Of Immunosuppression And Oral Glucocorticoids For Skin Fibrosis In Early Diffuse Systemic Sclerosis Patients. A Target Trial Emulation Study From The Eustar Database. In: Annals of the Rheumatic Diseases. EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria. BMJ Publishing Group .

Del Galdo, F. orcid.org/0000-0002-8528-2283, Lescoat, A., Conaghan, P.G. et al. (24 more authors) (2023) OP0234 2023 Update Of Eular Recommendations For The Treatment Of Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 154-155.

Bruni, C., Tofani, L., Fretheim, H. et al. (55 more authors) (2023) OP0238 Immunosuppression With Targeted Dmards Reduces Morbidity And Mortality In Pre-Capillary Pulmonary Hypertension Associated With Systemic Sclerosis: A Eustar Analysis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 157-159.

Lescoat, A., Chen, Y., Murphy, S.L. et al. (22 more authors) (2023) POS1258 Results from a nominal group technique exercise for the creation of a combined response index for limited cutaneous systemic sclerosis: The CRISTAL project. In: Annals of the Rheumatic Diseases. EULAR 2023 - European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 971-972.

Lazzaroni, M.G., Wilson, M., Hensor, E. orcid.org/0000-0002-5245-4755 et al. (15 more authors) (2022) POS0893 Factors to consider for measuring the effect of lung function on patient reported outcomes in Systemic Sclerosis patients: Analysis of the EUSTAR database. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 743-744.